deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01965119

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma (JAK2)

Sponsor: Samsung Medical Center

Conditions Primary Mediastinal Large B-cell Lymphoma Relapsed or Refractory Hodgkin Lymphoma
Interventions Ruxolitinib
Updated 8 times since 2017 Last updated: Oct 30, 2018 Started: Nov 15, 2013 Primary completion: Jun 30, 2017 Completion: Sep 18, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01965119, this PHASE2 trial focuses on Primary Mediastinal Large B-cell Lymphoma and Relapsed or Refractory Hodgkin Lymphoma and remains completed. Sponsored by Samsung Medical Center, it has been updated 8 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Nov 2017 · 10 months · monthly snapshotActive Not Recruiting~Nov 2017 – ~Jun 2018 · 7 months · monthly snapshotCompleted~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotCompleted~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Dec 2018 [monthly]

    Completed PHASE2

  2. Nov 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Jan 2017 — Nov 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Samsung Medical Center
Data source: Samsung Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations